Stress ulcer prophylaxis in the intensive care unit: An international survey of 97 units in 11 countries

Acta Anaesthesiologica Scandinavica

Volumn 59, Issue 5, 2015, Pages 576-585

  Krag, M ^a   Perner, A ^a   Wetterslev, J ^a   Wise, M P ^b   Borthwick, M ^c   Bendel, S ^d   McArthur, C ^e   Cook, D ^f   Nielsen, N ^g   Pelosi, P ^h   Keus, F ⁱ   Guttormsen, A B ^j   Moller, A D ^k   MOller M H ^a  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e AUCKLAND CITY HOSPITAL   (New Zealand)

^f MCMASTER UNIVERSITY   (Canada)

^g LUND UNIVERSITY   (Sweden)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^k LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; ANTIULCER AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; CLOSTRIDIUM DIFFICILE INFECTION; CRITICALLY ILL PATIENT; ENTERIC FEEDING; HIGH RISK PATIENT; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INTENSIVE CARE UNIT; OBSERVATIONAL STUDY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; STRESS ULCER; SURGICAL PATIENT; UNIVERSITY HOSPITAL; ADVERSE EFFECTS; COMPLICATION; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HEALTH CARE SURVEY; INTENSIVE CARE; MENTAL STRESS; ORGANIZATION AND MANAGEMENT; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; STATISTICS AND NUMERICAL DATA; STOMACH ULCER;

ANTI-ULCER AGENTS; CLOSTRIDIUM DIFFICILE; CRITICAL CARE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HEALTH CARE SURVEYS; HISTAMINE H2 ANTAGONISTS; HUMANS; INTENSIVE CARE UNITS; RESPIRATION, ARTIFICIAL; STOMACH ULCER; STRESS, PSYCHOLOGICAL;

EID: 84927740533     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12508     Document Type: Article

References (39)

1. Cook DJ, Griffith LE, Walter SD, Guyatt GH, Meade MO, Heyland DK, Kirby A, Tryba M,. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001; 5: 368-375.
2. Fennerty MB,. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression. Crit Care Med 2002; 30: 351-355.
3. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJ, Roy P,. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994; 330: 377-381.
4. Ben-Menachem T, Fogel R, Patel R V, Touchette M, Zarowitz BJ, Hadzijahic N, Divine G, Verter J, Bresalier RS,. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study. Ann Intern Med 1994; 121: 568-575.
5. Zandstra DF, Stoutenbeek CP,. The virtual absence of stress-ulceration related bleeding in ICU patients receiving prolonged mechanical ventilation without any prophylaxis. A prospective cohort study. Intensive Care Med 1994; 20: 335-340.
6. Plummer MP, Blaser AR, Deane AM,. Stress ulceration: prevalence, pathology and association with adverse outcomes. Crit Care 2014; 18: 213.
7. Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L, Tryba M,. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 1996; 275: 308-314.
8. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent J-L, Moreno R,. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165-228.
9. ASHP therapeutic guidelines on stress ulcer prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14 1998. Am J Health Syst Pharm 1999; 56: 347-379.
10. Rello J, Lode H, Cornaglia G, Masterton R,. A European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Med 2010; 36: 773-780.
11. Bavishi C, Dupont HL,. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther 2011; 34: 1269-1281.
12. Institute for Healthcare Improvement. IHI ventilator bundle: peptic ulcer disease prophylaxis [Internet]. 2014. [Cited 6 Jun 2014.] Available at: http://www.ihi.org/resources/Pages/Changes/PepticUlcerDiseaseProphylaxis.aspx.
13. Kaukonen K-M, Bailey M, Suzuki S, Pilcher D, Bellomo R,. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014; 311: 1308-1316.
14. Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Timsit J-F, Azoulay E,. Year in review in Intensive Care Medicine 2013: I. Acute kidney injury, ultrasound, hemodynamics, cardiac arrest, transfusion, neurocritical care, and nutrition. Intensive Care Med 2014; 40: 147-159.
15. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP,. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-349.
16. Farley KJ, Barned KL, Crozier TM,. Inappropriate continuation of stress ulcer prophylaxis beyond the intensive care setting. Crit Care Resusc 2013; 15: 147-151.
17. Gratrix AP, Enright SM, O'Beirne HA,. A survey of stress ulcer prophylaxis in intensive care units in the UK. Anaesthesia 2007; 62: 421-422.
18. Preslaski CR, Mueller SW, Kiser TH, Fish DN, MacLaren R,. A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit. J Clin Pharm Ther 2014; 39: 658-662.
19. Daley RJ, Rebuck JA, Welage LS, Rogers FB,. Prevention of stress ulceration: current trends in critical care. Crit Care Med 2004; 32: 2008-2013.
20. Erstad BL, Barletta JF, Jacobi J, Killian AD, Kramer KM, Martin SJ,. Survey of stress ulcer prophylaxis. Crit Care 1999; 3: 145-149.
21. Krag M, Perner A, Wetterslev J, Wise MP, Hylander Møller M,. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med 2014; 40: 11-22.
22. Barletta JF, Kanji S, MacLaren R, Lat I, Erstad BL,. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada. J Crit Care 2014; 29: 955-960.
23. Frandah W, Colmer-Hamood J, Nugent K, Raj R,. Patterns of use of prophylaxis for stress-related mucosal disease in patients admitted to the intensive care unit. J Intensive Care Med 2013; 29: 96-103.
24. Krag M, Perner A, Wetterslev J, Moller MH,. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review. Acta Anaesthesiol Scand 2013; 57: 835-847.
25. Hurt RT, Frazier TH, McClave SA, Crittenden NE, Kulisek C, Saad M, Franklin GA,. Stress prophylaxis in intensive care unit patients and the role of enteral nutrition. JPEN J Parenter Enteral Nutr 2012; 36: 721-731.
26. Farrell CP, Mercogliano G, Kuntz CL,. Overuse of stress ulcer prophylaxis in the critical care setting and beyond. J Crit Care 2010; 25: 214-220.
27. Grube RRA, May DB,. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm 2007; 64: 1396-1400.
28. Heidelbaugh JJ, Inadomi JM,. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol 2006; 101: 2200-2205.
29. Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK,. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012; 107: 1011-1019.
30. Howell M, Novack V, Grgurich P, Souillard D, Lena N, Pencina M, Talmor D,. Iatrogenic gastric acid suppression and the risk of nosocomial. Arch Intern Med 2010; 170: 784-790.
31. Leonard J, Marshall JK, Moayyedi P,. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007; 102: 2047-2056.
32. Maclaren R, Reynolds PM, Allen RR,. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med 2014; 174: 564-574.
33. Rezende-Neto JB, Rotstein OD,. Abdominal catastrophes in the intensive care unit setting. Crit Care Clin 2013; 29: 1017-1044.
34. Pakyz A, Carroll N V, Harpe SE, Oinonen M, Polk RE,. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers. Pharmacotherapy 2011; 31: 546-551.
35. Kantorova I, Svoboda P, Scheer P, Doubek J, Rehorkova D, Bosakova H, Ochmann J,. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 2004; 51: 757-761.
36. Marik PE, Vasu T, Hirani A, Pachinburavan M,. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med 2010; 38: 2222-2228.
37. Alhazzani W, Alenezi F, Jaeschke RZ, Moayyedi P, Cook DJ,. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med 2013; 41: 693-705.
38. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, Atkins D, Kunz R, Brozek J, Montori V, Jaeschke R, Rind D, Dahm P, Meerpohl J, Vist G, Berliner E, Norris S, Falck-Ytter Y, Murad MH, Schünemann HJ,. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol 2011; 64: 1311-1316.
39. Zandstra DF, van der Voort PHJ,. A more appropriate critical appraisal of the available evidence? Crit Care Med 2004; 32: 2166-2167, author reply 2167.